When do patients with retinitis pigmentosa present to ophthalmologists? A multi-centre retrospective study

Lucas Yan Bin Ng,Cheng Ze Ang,Tien-En Tan,Choi Mun Chan,Ranjana S. Mathur,Saadia Z. Farooqui,Penny Pooi Wah Lott,Rachael W. C. Tang,Beau J. Fenner
DOI: https://doi.org/10.1038/s41433-024-03368-8
IF: 4.4563
2024-09-26
Eye
Abstract:Planned gene therapies for retinitis pigmentosa (RP) depend on viable photoreceptors for efficacy. Understanding disease severity at presentation, and drivers that influence time to presentation is important when planning interventions. We examined features that influence RP severity at initial presentation.
ophthalmology
What problem does this paper attempt to address?